Literature DB >> 10371624

Endoscopic treatment of the trapped fourth ventricle

.   

Abstract

OBJECTIVE: To propose endoscopic treatment as an effective initial alternative for patients with a trapped fourth ventricle.
METHODS: We reviewed the records of the last 16 consecutive patients with a symptomatic trapped fourth ventricle seen at the Arkansas Children's Hospital. The first eight patients underwent a shunt procedure; the next eight had endoscopic procedures. The shunt procedures consisted of either separate shunts or combined supra- and infratentorial shunts with shared distal catheters. The endoscopic procedures consisted of either fenestration into the lateral ventricle or aqueductal plasty with or without a stent.
RESULTS: All patients underwent successful procedures with good outcomes, although the patients with shunts appeared to have a higher-than-expected rate of revision (50%). Seven revisions were performed on four patients, with a complication rate of 25%. Of the patients who had endoscopic procedures, one eventually required a shunt. The overall complication rate for patients who had endoscopic procedures was also 25%.
CONCLUSION: Endoscopic treatment of the trapped fourth ventricle is effective in most cases. In view of the higher-than-expected revision rate with fourth ventricular shunts and an equivalent complication rate, endoscopic treatment is a reasonable initial treatment option for patients with a trapped fourth ventricle.

Entities:  

Year:  1999        PMID: 10371624

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  11 in total

Review 1.  Management strategies for treatment of the trapped fourth ventricle.

Authors:  David H Harter
Journal:  Childs Nerv Syst       Date:  2004-07-15       Impact factor: 1.475

2.  Endoscopic aqueductoplasty in the treatment of aqueductal stenosis.

Authors:  Luciano Ricardo França da Silva; Sérgio Cavalheiro; Samuel Tau Zymberg
Journal:  Childs Nerv Syst       Date:  2007-08-04       Impact factor: 1.475

3.  Bilateral abducent and facial nerve palsies following fourth ventricle shunting: two case reports.

Authors:  Pietro Spennato; Donncha F O'Brien; John P Fraher; Conor L Mallucci
Journal:  Childs Nerv Syst       Date:  2005-01-22       Impact factor: 1.475

Review 4.  Historical trends of neuroendoscopic surgical techniques in the treatment of hydrocephalus.

Authors:  Yavor Enchev; Shizuo Oi
Journal:  Neurosurg Rev       Date:  2008-05-08       Impact factor: 3.042

5.  Endoscopic transaqueductal or interventricular stent placement for the treatment of isolated fourth ventricle and pre-isolated fourth ventricle.

Authors:  Hideki Ogiwara; Nobuhito Morota
Journal:  Childs Nerv Syst       Date:  2013-04-23       Impact factor: 1.475

6.  Cranial expansion and aqueductoplasty for combined isolated fourth ventricle and slit-ventricle syndrome: a surgical alternative.

Authors:  Jorge Tirado-Caballero; Mónica Rivero-Garvia; Gloria Moreno-Madueño; Emilio Gómez-González; Javier Márquez-Rivas
Journal:  Childs Nerv Syst       Date:  2020-10-25       Impact factor: 1.475

7.  Endoscopic aqueductoplasty.

Authors:  Yusuf Erşahin
Journal:  Childs Nerv Syst       Date:  2006-10-13       Impact factor: 1.475

8.  Radiologic and clinical outcome of isolated fourth ventricle following post-hemorrhagic hydrocephalus in children.

Authors:  Rida Salman; Thierry A G M Huisman; Stephen Kralik; Avner Meoded; Nilesh K Desai; Samuel G McClugage; Eugen Boltshauser; Gunes Orman
Journal:  Childs Nerv Syst       Date:  2022-03-19       Impact factor: 1.475

9.  Endoscopic aqueductoplasty: stent or not to stent?

Authors:  Michael J Fritsch; Sven Kienke; H Maximilian Mehdorn
Journal:  Childs Nerv Syst       Date:  2003-12-19       Impact factor: 1.475

10.  Proposed radiological score for the evaluation of isolated fourth ventricle treated by endoscopic aqueductoplasty.

Authors:  Leopoldo Mandic Ferreira Furtado; José Aloysio da Costa Val Filho; Alexandre Varella Giannetti
Journal:  Childs Nerv Syst       Date:  2020-10-24       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.